
In order to help combat the national prescription drug abuse epidemic, CVS Caremark is tapping its extensive database to identify and halt inappropriate prescribing of high-risk drugs such as opioid painkillers.

In order to help combat the national prescription drug abuse epidemic, CVS Caremark is tapping its extensive database to identify and halt inappropriate prescribing of high-risk drugs such as opioid painkillers.

Filling a prescription at a doctor’s office may be convenient, but it’s certainly no bargain for patients or taxpayers, according to an analysis of workers’ compensation payouts in Maryland and Pennsylvania.

In hopes of decreasing opioid abuse, addictions, and overdose deaths, FDA this week announced safety-labeling changes for all extended-release and long-acting (ER/LA) opioid analgesics used to treat pain. FDA has also added new postmarket study requirements for opioids such as morphine, oxycodone, and fentanyl.

Children who miss diphtheria, tetanus toxoid, and acellular pertussis (DTaP) vaccine doses are at more likely to develop whooping cough, according to a study in JAMA Pediatrics.

FDA expanded the approved uses of paclitaxel protein-bound particles for injectable suspension, albumin-bound (Abraxane, Celgene) to treat patients with metastatic pancreatic cancer.

In an effort to help facilitate accurate and uniform records of US vaccine usage, the Centers for Disease Control and Prevention (CDC) and immunization community stakeholders are exploring the potential of 2-dimensional (2D) barcoding to streamline immunization practices.

At least one quarter of the 800,000 deaths annually attributed to cardiovascular disease could be prevented if people stopped smoking, reduced salt intake, and adopted other healthy habits, according to a report by the U.S. Centers for Disease Control and Prevention (CDC).

Knowing which patients are most at-risk for adverse drug events would help hospitals direct pharmacist-led counseling services to those who need it the most. The American Society of Health-System Pharmacists (ASHP) Foundation is funding research it believes will make it easier to identify those patients.

New regulations in the Patient Protection and Affordable Care Act have led to the birth of essential health benefits. The Centers for Medicare and Medicaid Services’ (CMS) new division, the Center for Consumer Information and Insurance Oversight (CCIIO), is responsible for the oversight of the insurance offerings on the new health insurance exchanges, which have 10 required essential health benefit categories. One of these essential categories is prescription drugs. Prospective qualified health plans, prescription benefit managers, and consultant agencies have struggled through the legislation and guidance from CCIIO in an attempt to build benefits that meet the requirements. With elements of typical commercial offerings as well as those of Medicare Part D, there are many nuances that one must consider when building an exchange formulary and creating the surrounding benefit.

Guillain-Barre syndrome (GBS) is an immune-mediated flaccid paralysis that can range from muscle weakness and tingling to respiratory paralysis requiring prolonged respiratory support and ventilation. Overall, GBS is a rare disease, with annual incidence averaging 1 to 2 cases per 100,000 individuals.1

Catamaran, a pharmacy benefits manager (PBM) has been on a buying binge since 2008, snapping up its sixth PBM, Restat. The $409.5 million cash purchase is expected to close in the fourth quarter of 2013.

In a study of patients with alcohol dependence and post-traumatic stress disorder (PTSD), treatment with naltrexone resulted in a decrease in the percentage of patient drinking days. Prolonged exposure therapy was not associated with an exacerbation of alcohol-use disorder.


Children and youth on antipsychotics appear to have a 3-fold increased risk for type 2 diabetes mellitus, according to a study published by JAMA Psychiatry.

Kaiser Permanente (KP) Northern California nearly doubled the rate of blood pressure control among adult members with diagnosed hypertension between 2001 and 2009 through a large-scale community-based program, the Journal of the American Medical Association reported recently.

In a Drug Safety Communication, FDA has reported that a patient in Europe being treated for multiple sclerosis and who had no history of using natalizumab (Tysabri) developed progressive multifocal leukoencephalopathy (PML) while taking fingolimod (Gilenya).

Eleven states have reduced antipsychotic use in nursing home residents by at least 15%, meeting a CMS partnership goal set last year.

The new fixed-combination of brinzolamide 1% plus brimonidine 0.2% (Simbrinza Suspension, Alcon Laboratories) is a safe and effective option for lowering IOP in patients with glaucoma or ocular hypertension uncontrolled on monotherapy.

One in 10 Americans admit taking someone else’s Rx, according to an ongoing Reuters/psos online survey. About a quarter of those people used the prescription drugs to get high, according to the survey

Insulin pumps control blood sugar in children with diabetes better than insulin injections, according to a new study.

Priority review, breakthrough therapy, fast-track designations, orphan drug designations, first-time generic approval

FDA approvals

Drinking large amounts of coffee may be bad for under-55s, according to a recent study published in Mayo Clinic Proceedings.

Pharmacists in Canada were recently given broader responsibilities including, in certain provinces, prescribing privileges, vaccination abilities, and the ability to order and interpret laboratory tests. This newly expanded role for Canadian pharmacists can benefit both patients and physicians, according to an article in the Canadian Medical Association Journal.

Drug evaluation and selection models are changing. Safety and efficacy have become the starting point for consideration by many payers. What they really want to see is evidence of superior performance in real world patient populations.

According to FDA, the risk of peripheral neuropathy occurs only with fluoroquinolones that are taken by mouth or by injection.